Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

Researchers at Weill Cornell Medicine and the Burke Neurological Institute have made an exciting discovery—a new drug that ...

Neuropathic pain is a severe clinical condition caused by damage to the nervous system. It often feels like a burning, ...

Fewer Cognitive Side Effects: With the potential to avoid sedation and cognitive impairment, Ketamir-2 offers an improved ...

Objective: To assess the efficacy, safety and impact on quality of life of tramadol in the treatment of neuropathic pain in patients with cancer. Methods: Patients with similar characteristics ...

Cannabidiol (CBD) holds great promise as a treatment for many health concerns, including inflammation. For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain.

Ketamir-2, a non-opioid, offers tremendous promise for patients seeking better solutions for neuropathic pain without the ... promising alternative to current treatments. Ketamir-2 offers several ...

The Phase III trial AV001 aims to evaluate QUTENZA ® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...

Long-term, low-dose antiviral treatment reduces the risk for potentially ... ligands on murine neuropathic pain models, their effects on nociceptive neurons and the mechanism of action after ...

The firm says it could offer an alternative to existing treatments while sidestepping addiction concerns that have plagued ...

According to OKYO Pharma, OK-101 is the first drug candidate to enroll patients specifically diagnosed with neuropathic ...

European researchers have mapped the most comprehensive phenotyping of neuropathic pain and identified genetic markers associated with this serious condition.